UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040078
Receipt number R000045702
Scientific Title Enhanced relaxation effect of music therapy with Artificial Reality: a study of reliability and validity
Date of disclosure of the study information 2020/04/06
Last modified on 2020/06/10 18:45:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Enhanced relaxation effect of music therapy with Artificial Reality: a study of reliability and validity

Acronym

Enhanced relaxation effect of music therapy with Artificial Reality

Scientific Title

Enhanced relaxation effect of music therapy with Artificial Reality: a study of reliability and validity

Scientific Title:Acronym

Enhanced relaxation effect of music therapy with Artificial Reality

Region

Japan


Condition

Condition

healthy

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Demonstrate healing effects by providing medical students with artificial reality and music

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

State Trait Anxiety Inventory STAI

Key secondary outcomes

level of cortisol in saliva
level of amylase in saliva


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

1

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Other

Interventions/Control_1

Mindfulness program

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. healthy adults
2. Anyone with a medical condition needs permission from your doctor

Key exclusion criteria

1. Being treated for a psychiatric disorder
2. Those who were judged inappropriate by a researcher in this study for some other reason

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Aitsush
Middle name
Last name Ohashi

Organization

Fujita Health University

Division name

School of Medical Sciences Department of Clinical Engineering Technology

Zip code

470-1192

Address

1-98 Dengakugakubo,Kutsukake-cho,Toyoake, Aichi 470-1192,JAPAN

TEL

0562-93-9250

Email

aohashi@fujita-hu.ac.jp


Public contact

Name of contact person

1st name Aitsush
Middle name
Last name Ohashi

Organization

Fujita Health University

Division name

School of Medical Sciences Department of Clinical Engineering Technology

Zip code

470-1192

Address

1-98 Dengakugakubo,Kutsukake-cho,Toyoake, Aichi 470-1192,JAPAN

TEL

0562-93-2614

Homepage URL


Email

aohashi@fujita-hu.ac.jp


Sponsor or person

Institute

Fujita Health University

Institute

Department

Personal name



Funding Source

Organization

Fujita Health University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The ethics committee of Fujita Health University.

Address

1-98 Dengakugakubo,Kutsukake-cho,Toyoake, Aichi 470-1192,JAPAN

Tel

0562-93-2865

Email

r-irb@fujita-hu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

藤田医科大学


Other administrative information

Date of disclosure of the study information

2020 Year 04 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2020 Year 04 Month 06 Day

Date of IRB

2020 Year 06 Month 09 Day

Anticipated trial start date

2020 Year 04 Month 15 Day

Last follow-up date

2021 Year 01 Month 10 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 04 Month 06 Day

Last modified on

2020 Year 06 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045702